Big pharma likes orthomed if they can make money off it.

You'll note the difference between the above and the standard decades old orthomolecular cure for IBS is the addition of a brand new antibiotic. The rest is straght out of 20 year old orthomed journals.

You could of course, use oregano oil instead of the antibiotic, but that's not newsworthy.

Big pharma spends million vilifying orthomolecular protocols, but as soon as they can make money of some aspect of it, all of a sudden that protocol is ground-breaking.

Never mind the lives they could have saved over those decades while they were railing against the treatment they now claim is a breakthrough (and that they can finally make money off).

Richard Sexton
May 16, 2010